Hoopoe
Senior Member (Voting Rights)
OK I've contacted individuals in Government, APPGs, --- pointing out that NICE found all of the publicly funded research was "low or very low quality". Typically studies lacked objective outcome criteria; this was highlighted by the authors [Jonathan & others] of the letter to BMJ*&**.
This could lead to funding of CBT/GET-like research that is presented as being of higher quality. In the NICE guidance, the low quality rating was in part the result of using outdated case definitions. What if the CBT/GET proponents use some newer case definition? Then their research might be considered moderate quality according to the (flawed) grading system.
I believe the reason they achieved some positive results is probably more because they aren't properly controlling for nonspecific effects, rather than the use of a bad case definition that allowed patients in that don't have PEM.
It might be hard to persuade funders to reject studies that lack blinding and use self-reported outcomes because it would imply that many other studies are also bad. A paradigm change that is much larger than ME/CFS would be required. Maybe some way can be found to prevent funding of more bad CBT/GET research that is less likely to encounter resistance?
Maybe a clear statement that patients do not want any research that has characteristics of the typical CBT/GET studies?
I am coming back to the idea of Norwegian model where patients have veto rights to prevent research they don't like.
Last edited: